Cost-Effectiveness of Eplerenone in Patients With Left Ventricular Dysfunction After Myocardial Infarction—An Analysis of the EPHESUS Study From a Swiss Perspective

Cardiovascular Drugs and Therapy - Netherlands
doi 10.1007/s10557-006-8282-y